MicuRx plans to raise no more than 1.033 billion yuan through a private placement to HaiJing Pharmaceutical for research and operational investment
I'm LongbridgeAI, I can summarize articles.
MicuRx plans to raise no more than 1.033 billion yuan through a private placement to Haijing Pharmaceutical, issuing 164 million shares at a price of 6.30 yuan per share. The raised funds will be used for the company's daily research and development and operational investments. After this issuance, Haijing Pharmaceutical will become the controlling shareholder, and Zhang Xiantao will become the actual controller
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments